A Multi-center, Prospective, Randomized, Double-blind Study to Assess the Impact of Sacubitril/Valsartan vs. Enalapril on Daily Physical Activity Using a Wrist Worn Actigraphy Device in Adult Chronic Heart Failure Patients
Phase of Trial: Phase III
Latest Information Update: 17 Apr 2018
At a glance
- Drugs Sacubitril/valsartan (Primary) ; Enalapril
- Indications Chronic heart failure
- Focus Registrational; Therapeutic Use
- Acronyms OUTSTEP-HF
- Sponsors Novartis; Novartis Pharma A.G.; Novartis Pharmaceuticals
- 14 Apr 2018 This trial has been completed in Netherlands.
- 12 Apr 2018 This trial has been completed in Spain.
- 28 Mar 2018 The study has been completed in Bulgaria.